These Were the 3 Top-Performing Stocks in the Nasdaq-100 in August 2025

Source Motley_fool

Key Points

  • Intel was the Nasdaq-100 index's top performer in August 2025, lifted by a rare financing deal with the U.S. government.

  • AppLovin nearly matched Intel's gains, based on yet another analyst-stumping earnings report from the mobile marketing expert.

  • Next comes Idexx Labs, whose pet-care products and services saw robust growth in Q2 2025.

  • 10 stocks we like better than AppLovin ›

The Nasdaq-100 traded almost exactly sideways in August 2025, posting a 0.9% gain. But it wasn't a slow period for everybody. Three Nasdaq-100 titans saw August gains of 20% or more, for very different reasons.

1. Intel: Up 23%

Semiconductor giant Intel (NASDAQ: INTC) led the charge with a 23% gain in August. Coming off a painful drop in July and several years of generally bearish stock market trends, Intel finally caught a break. The Trump administration struck a deal to acquire 9.9% of Intel's stock, creating a unique financing relationship between the U.S. government and a public company.

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More »

The deal didn't unlock a huge single-day price gain, but more of a slow rise as deal details started hitting the rumor mill. It also didn't cure every problem Intel faces, and the stock still trades 10% below its 2025 highs.

As a longtime shareholder, I'm still wondering whether this financing agreement is a good thing for Intel or a dilutive event for stock owners -- and it could be both.

2. AppLovin: Up 22.5%

Mobile marketing expert AppLovin (NASDAQ: APP) comes next, with a 22.5% August return. The company published second-quarter results on Aug. 6, crushing Wall Street's bottom-line projections and sending stock prices 12% higher the next day. AppLovin has been building on these gains, setting fresh all-time highs on a nearly daily basis recently.

A person smiles at a tablet computer in their hands.

Image source: Getty Images.

AppLovin's Q2 revenues jumped 77% year over year, while adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) doubled. Many companies come up with adjusted profit metrics to shine a more bullish light on their financial results. But AppLovin moved in the opposite direction, as unadjusted net profits increased by a stunning 164%.

3. Idexx Laboratories: Up 21.1%

Finally, Idexx Laboratories (NASDAQ: IDXX) enjoyed a 21.1% return in August. The pet healthcare specialist also posted Q2 results early in the month, impressing investors with a clean beat-and-raise performance.

Idexx saw particularly strong growth in consumable pet-care products and recurring service revenues. A recently launched cancer test for dogs posted strong sales in North America, while management worked to expand its reach internationally.

The company can't quite keep up with AppLovin's explosive growth, but it's still a healthy growth investment. Expect to continue paying a growth-based premium for this stock.

Should you invest $1,000 in AppLovin right now?

Before you buy stock in AppLovin, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and AppLovin wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $649,037!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,086,028!*

Now, it’s worth noting Stock Advisor’s total average return is 1,056% — a market-crushing outperformance compared to 188% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.

See the 10 stocks »

*Stock Advisor returns as of September 8, 2025

Anders Bylund has positions in Intel. The Motley Fool has positions in and recommends Intel. The Motley Fool recommends Idexx Laboratories and recommends the following options: short November 2025 $21 puts on Intel. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Asian Stocks Climb on US AI Optimism; Japan’s Nikkei Reaches New Record HighMost Asian stock markets climbed on Thursday, with China leading gains fueled by renewed optimism around U.S. artificial intelligence developments.
Author  Mitrade
Yesterday 06: 06
Most Asian stock markets climbed on Thursday, with China leading gains fueled by renewed optimism around U.S. artificial intelligence developments.
placeholder
Dollar Holds Steady Amid Inflation Data and Central Bank WatchThe U.S. dollar steadied in early Asian trading on Thursday following an unexpected 0.1% decline in the Producer Price Index (PPI) for final demand in August, as reported by the Labor Department’s Bureau of Labor Statistics.
Author  Mitrade
Yesterday 02: 44
The U.S. dollar steadied in early Asian trading on Thursday following an unexpected 0.1% decline in the Producer Price Index (PPI) for final demand in August, as reported by the Labor Department’s Bureau of Labor Statistics.
placeholder
Barclays Boosts S&P 500 Outlook Amid Strong AI-Driven EarningsBarclays has increased its earnings and price projections for the S&P 500 through 2025 and 2026, attributing the upgrade to stronger-than-anticipated corporate results in the first half of the year and a robust earnings landscape despite trade tensions and labor challenges.
Author  Mitrade
Sept 10, Wed
Barclays has increased its earnings and price projections for the S&P 500 through 2025 and 2026, attributing the upgrade to stronger-than-anticipated corporate results in the first half of the year and a robust earnings landscape despite trade tensions and labor challenges.
placeholder
ANZ Raises Gold Price Forecast to $3,800/Oz, Predicts Rally to Continue Through 2026Gold is expected to continue its upward momentum throughout 2025 and into early 2026, driven by ongoing geopolitical tensions, macroeconomic challenges, and market anticipation of U.S. monetary easing, according to analysts from ANZ in a research note released Wednesday.
Author  Mitrade
Sept 10, Wed
Gold is expected to continue its upward momentum throughout 2025 and into early 2026, driven by ongoing geopolitical tensions, macroeconomic challenges, and market anticipation of U.S. monetary easing, according to analysts from ANZ in a research note released Wednesday.
placeholder
Dollar steadies before U.S. jobs data; euro pressured by French turmoilThe U.S. dollar edged higher Tuesday, stabilizing after a slide to seven-week lows as traders looked ahead to key labor and inflation data expected to lock in a Federal Reserve rate cut next week.
Author  Mitrade
Sept 09, Tue
The U.S. dollar edged higher Tuesday, stabilizing after a slide to seven-week lows as traders looked ahead to key labor and inflation data expected to lock in a Federal Reserve rate cut next week.
goTop
quote